Skip to main content
BrainCited

Ginkgo biloba.

Victor S Sierpina, Bernd Wollschlaeger, Mark Blumenthal
Review American family physician 2003
PubMed
<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'pmid\u003D13678141'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Tipo di studio
Review
Popolazione
Dementia and cerebrovascular disease patients
Intervento
Ginkgo biloba. Ginkgo biloba extract
Comparatore
None
Esito primario
Dementia and cerebrovascular disease treatment
Direzione dell'effetto
Positive
Rischio di bias
Unclear

Abstract

Ginkgo biloba is commonly used in the treatment of early-stage Alzheimer's disease, vascular dementia, peripheral claudication, and tinnitus of vascular origin. Multiple trials investigating the efficacy of ginkgo for treating cerebrovascular disease and dementia have been performed, and systematic reviews suggest the herb can improve the symptoms of dementia. Ginkgo is generally well tolerated, but it can increase the risk of bleeding if used in combination with warfarin, antiplatelet agents, and certain other herbal medications. Clinical issues of safety, dosing, use in the perioperative period, and pharmacology are addressed in this review.

Used In Evidence Reviews

Similar Papers